Literature DB >> 20661833

Apple, cherry, and blackcurrant increases nuclear factor kappa B activation in liver of transgenic mice.

Trude R Balstad1, Ingvild Paur, Morten Poulsen, Jaroslaw Markowski, Krzysztof Kolodziejczyk, Lars O Dragsted, Mari C W Myhrstad, Rune Blomhoff.   

Abstract

Nuclear factor kappa B (NF-kappaB) is essential in normal physiology, and several human disorders involve inappropriate regulation of NF-kappaB. Diets dominated by plant-based foods protect against chronic diseases, and several food derived compounds have been identified as promising NF-kappaB modulators. We investigated the effects of diets supplemented with apple, blackcurrant, or cherries on lipopolysaccharide (LPS)-induced NF-kappaB activation in transgenic NF-kappaB-luciferase mice. Whole body and organ specific NF-kappaB activities were determined. The mice had ad libitum access to the respective experimental diets for 7 days. On Day 7, all mice were given an LPS-injection (2.5 mg/kg), and NF-kappaB activation was monitored by in vivo imaging for 6 h. After imaging, blood samples were taken, the mice were euthanized, and ex vivo imaging of organs was performed. Compared to the control group, the apple and cherry groups had slightly higher whole-body NF-kappaB activation at 4 h, and all 3 experimental groups had higher NF-kappaB activation at 6 h. LPS-induced NF-kappaB activation in liver was increased with all 3 experimental diets, but no effects were observed in other organs. Our findings indicate that high intakes of lyophilized fruits modulate in vivo NF-kappaB signaling in the liver following LPS-induced stress; however, consequences of this NF-kappaB modulation in hepatic tissue needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661833     DOI: 10.1080/01635581003695749

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  1 in total

1.  The Norwegian dietary guidelines and colorectal cancer survival (CRC-NORDIET) study: a food-based multicentre randomized controlled trial.

Authors:  Hege Berg Henriksen; Hanna Ræder; Siv Kjølsrud Bøhn; Ingvild Paur; Ane Sørlie Kværner; Siv Åshild Billington; Morten Tandberg Eriksen; Gro Wiedsvang; Iris Erlund; Arne Færden; Marit Bragelien Veierød; Manuela Zucknick; Sigbjørn Smeland; Rune Blomhoff
Journal:  BMC Cancer       Date:  2017-01-30       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.